Crescent Capital BDC earnings beat by $0.01, revenue fell short of estimates
#Crescent Capital BDC #Earnings Report #EPS Beat #Revenue Miss #NASDAQ: CCAP #Business Development Company #Stock Performance
📌 Key Takeaways
- Crescent Capital BDC beat EPS estimates by $0.01 with $0.45
- Revenue of $40.8M missed estimates of $41.76M
- Stock is down 7.53% in last 3 months and 26.60% in last 12 months
- Company has 'good performance' financial health score despite recent negative EPS revisions
📖 Full Retelling
Crescent Capital BDC (NASDAQ: CCAP) reported fourth quarter earnings on February 25, 2026, beating analyst expectations by $0.01 per share while falling short on revenue estimates, reflecting the mixed performance of business development companies in the current economic climate. The company announced earnings per share of $0.45, surpassing the consensus estimate of $0.44, but reported quarterly revenue of $40.8 million, which fell below the expected $41.76 million. Despite beating earnings estimates, Crescent Capital BDC's stock closed at $13.27, continuing a downward trend that has seen the stock decline 7.53% over the past three months and 26.60% over the past year. The company's financial health was rated as 'good performance' by InvestingPro, though it has faced more negative EPS revisions (4) than positive ones (1) in the last 90 days, indicating some analyst concern about future performance.
🏷️ Themes
Earnings Results, Market Performance, Financial Health
📚 Related People & Topics
Business Development Company
Type of investment company in the United States
A Business Development Company ("BDC") is a form of unregistered closed-end investment company in the United States that invests in small and mid-sized businesses. This form of company was created by the US Congress in 1980 in the amendments to the Investment Company Act of 1940. Publicly filing fir...
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Nasdaq ends more than 1% higher as Nvidia rises pre-earnings, tech extends rebound Gold prices head for fifth day of gains in six; JPMorgan sees more upside Nvidia set to report strong results and guidance, analysts say Nvidia quells AI demand fears with strong revenue guidance, stock up after hours (South Africa Philippines Nigeria) Crescent Capital BDC earnings beat by $0.01, revenue fell short of estimates By Investing.com Earnings Published 02/25/2026, 07:15 PM Crescent Capital BDC earnings beat by $0.01, revenue fell short of estimates 0 CCAP 3.03% Investing.com - Crescent Capital BDC (NASDAQ: CCAP ) reported fourth quarter EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $40.8M versus the consensus estimate of $41.76M. Crescent Capital BDC’s stock price closed at $13.27. It is down -7.53% in the last 3 months and down -26.60% in the last 12 months. Crescent Capital BDC saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Crescent Capital BDC’s stock price’s past reactions to earnings here . According to InvestingPro , Crescent Capital BDC’s Financial Health score is " good performance ". Check out Crescent Capital BDC’s recent earnings performance , and Crescent Capital BDC’s financials here . Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Read full article at source